
David Roman
Stock Analyst at Goldman Sachs
(3.33)
# 2,395
Out of 5,189 analysts
245
Total ratings
52.1%
Success rate
3.6%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Reiterated: Buy | $98 → $115 | $101.85 | +12.91% | 19 | Nov 5, 2026 | |
| BAX Baxter International | Rated: Hold | $17 → $21 | $25.39 | -17.29% | 20 | Jul 15, 2026 | |
| BBNX Beta Bionics | Rated: Buy | $17 → $19 | $13.36 | +42.22% | 7 | Jul 15, 2026 | |
| BLCO Bausch + Lomb | Reiterated: Hold | $19 → $21 | $19.38 | +8.36% | 4 | Jul 14, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $71 → $57 | $41.98 | +35.78% | 11 | Jul 14, 2026 | |
| MOBI Mobia Medical | Reiterated: Buy | $31 | $11.85 | +161.60% | 2 | Jul 14, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Hold | $21 → $16 | $17.46 | -8.36% | 7 | Jul 14, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $558 | $399.05 | +39.83% | 21 | Jun 15, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $26 → $25 | $11.87 | +110.62% | 7 | Jun 10, 2026 | |
| MDT Medtronic | Reiterated: Hold | $84 → $83 | $99.94 | -16.95% | 12 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $24 | $16.01 | +49.91% | 2 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 → $113 | $103.00 | +9.71% | 13 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $89 → $88 | $94.75 | -7.12% | 5 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $73 → $61 | $58.88 | +3.60% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 → $205 | $133.17 | +53.94% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $8 | $7.45 | +7.38% | 8 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 | $237.31 | -35.53% | 4 | May 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $28 → $24 | $28.73 | -16.46% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $79.32 | +0.86% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $20.15 | -0.74% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $73 → $72 | $90.73 | -20.64% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $50 | $37.04 | +34.99% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $16 | $17.42 | -8.15% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $54 → $66 | $84.50 | -21.89% | 2 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $357 → $361 | $310.00 | +16.45% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $80.64 | - | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $147 | $94.72 | +55.19% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $192 → $167 | $212.78 | -21.52% | 5 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $17 | $25.10 | -32.27% | 7 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $93 → $88 | $101.10 | -12.96% | 8 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $21 | $66.89 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $39 → $29 | $120.16 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $103 | $106.38 | n/a | 1 | Nov 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $44 → $15 | $6.08 | n/a | 2 | Aug 30, 2012 |
Edwards Lifesciences
Nov 5, 2026
Reiterated: Buy
Price Target: $98 → $115
Current: $101.85
Upside: +12.91%
Baxter International
Jul 15, 2026
Rated: Hold
Price Target: $17 → $21
Current: $25.39
Upside: -17.29%
Beta Bionics
Jul 15, 2026
Rated: Buy
Price Target: $17 → $19
Current: $13.36
Upside: +42.22%
Bausch + Lomb
Jul 14, 2026
Reiterated: Hold
Price Target: $19 → $21
Current: $19.38
Upside: +8.36%
Boston Scientific
Jul 14, 2026
Reiterated: Buy
Price Target: $71 → $57
Current: $41.98
Upside: +35.78%
Mobia Medical
Jul 14, 2026
Reiterated: Buy
Price Target: $31
Current: $11.85
Upside: +161.60%
Tandem Diabetes Care
Jul 14, 2026
Reiterated: Hold
Price Target: $21 → $16
Current: $17.46
Upside: -8.36%
Intuitive Surgical
Jun 15, 2026
Reiterated: Buy
Price Target: $558
Current: $399.05
Upside: +39.83%
Omada Health
Jun 10, 2026
Reiterated: Buy
Price Target: $26 → $25
Current: $11.87
Upside: +110.62%
Medtronic
Jun 4, 2026
Reiterated: Hold
Price Target: $84 → $83
Current: $99.94
Upside: -16.95%
Jun 3, 2026
Reiterated: Buy
Price Target: $14 → $24
Current: $16.01
Upside: +49.91%
May 31, 2026
Reiterated: Buy
Price Target: $121 → $113
Current: $103.00
Upside: +9.71%
May 29, 2026
Reiterated: Sell
Price Target: $89 → $88
Current: $94.75
Upside: -7.12%
May 27, 2026
Reiterated: Sell
Price Target: $73 → $61
Current: $58.88
Upside: +3.60%
May 27, 2026
Reiterated: Buy
Price Target: $237 → $205
Current: $133.17
Upside: +53.94%
May 27, 2026
Reiterated: Buy
Price Target: $7 → $8
Current: $7.45
Upside: +7.38%
May 25, 2026
Reiterated: Buy
Price Target: $153
Current: $237.31
Upside: -35.53%
May 15, 2026
Rated: Hold
Price Target: $28 → $24
Current: $28.73
Upside: -16.46%
May 15, 2026
Reiterated: Buy
Price Target: $80
Current: $79.32
Upside: +0.86%
May 13, 2026
Reiterated: Buy
Price Target: $20
Current: $20.15
Upside: -0.74%
May 6, 2026
Reiterated: Hold
Price Target: $73 → $72
Current: $90.73
Upside: -20.64%
May 6, 2026
Reiterated: Buy
Price Target: $54 → $50
Current: $37.04
Upside: +34.99%
May 5, 2026
Reiterated: Buy
Price Target: $17 → $16
Current: $17.42
Upside: -8.15%
May 5, 2026
Reiterated: Sell
Price Target: $54 → $66
Current: $84.50
Upside: -21.89%
May 1, 2026
Reiterated: Hold
Price Target: $357 → $361
Current: $310.00
Upside: +16.45%
Apr 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $80.64
Upside: -
Apr 30, 2026
Reiterated: Hold
Price Target: $147
Current: $94.72
Upside: +55.19%
Apr 10, 2026
Initiated Coverage: Hold
Price Target: $192 → $167
Current: $212.78
Upside: -21.52%
Apr 9, 2026
Rated: Hold
Price Target: $24 → $17
Current: $25.10
Upside: -32.27%
Feb 10, 2026
Reiterated: Sell
Price Target: $93 → $88
Current: $101.10
Upside: -12.96%
May 16, 2016
Downgraded: Sell
Price Target: $18 → $21
Current: $66.89
Upside: n/a
May 16, 2016
Upgraded: Hold
Price Target: $39 → $29
Current: $120.16
Upside: n/a
Nov 15, 2013
Reiterated: Sell
Price Target: $103
Current: $106.38
Upside: n/a
Aug 30, 2012
Reiterated: Hold
Price Target: $44 → $15
Current: $6.08
Upside: n/a